计算溶液所需的质量、体积或浓度。
Deflazacort 是一种糖皮质激素,是一种抗炎剂和免疫抑制剂。A systemic corticosteroid.
Information
Deflazacort Deflazacort (MDL 458) is a glucocorticoid used as an anti-inflammatory and immunosuppressant.
In vitro
In vivo
Deflazacort results in a significant and equal decrease of thymus weight, indicating a marked reduction in total immunogenic tissue in rats. Deflazacort reduces thymus weight and Daily weight gain in rats. Deflazacort lowers liver IFG-I and GHR mRNA in rats. Deflazacort (DFC) is a heterocyclic glucocorticoid with anti-inflammatory activity but with decreased side effects. Deflazacort and [3H]dexamethasone (DEX) similarly induce in vivo ornithine decarboxylase activity in hippocampus and liver, although body weight loss after chronic treatment is significantly less for DFC. Deflazacort induces dose-dependent decreases in osteocalcin (OC) plasma production rate (PPR). Deflazacort and prednisolone increase both postabsorptive plasma glucose and plasma calcium levels in sheep, but there are no significant differences between their effects. Deflazacort, especially combined with L-arginine, spares quadriceps muscle from injury-induced regeneration (myf5 expression) compared with placebo treatment, despite an increase in membrane permeability immediately after exercise. Deflazacort alone prevents the typical progressive loss of function (measured as voluntary distance run over 24 hours) that is observed 3 months later in placebo-treated mice. Deflazacort causes a less significant alteration in the pattern of GH secretion and does not negatively affect the overall amount of GH secreted.
Cell Data
cell lines:Colon cancer cell lines DLD-1, LoVo, HCT15, and Colo205
Concentrations:
Incubation Time:
Powder Purity:≥99%
| ALogP | 2 |
|---|
H373: 长期或反复接触可能对器官造成伤害
H360: 可能对生育能力或胎儿造成伤害
H361: 怀疑破坏生育力或未出生的孩子
P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。
P405: 密闭存放
P501: 将内容物/容器送到批准的废物处理厂处理
P260: 不要吸入灰尘/烟雾/气体/雾/蒸汽/喷雾。
P203: 使用前,获取、阅读并遵守所有安全说明。
P318: 如果暴露或担心,请就医。
P319: 如果你感到不适,请寻求医疗帮助。